on December 30, 2002
Published online before print December 30, 2002, doi: 10.1161/01.HYP.0000051641.58674.F7
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 1, 2002
From the Department of Medicine and Pharmacology and Toxicology, Michigan State University, East Lansing. * To whom correspondence should be addressed. E-mail: donna.wang{at}ht.msu.edu.
Abstract—To test the hypothesis that activation of the vanilloid receptor (VR1) contributes to the anandamide-induced depressor effect in spontaneously hypertensive rats (SHR), we used a selective VR1 antagonist capsazepine (CAPZ) and a selective cannabinoid type 1 receptor antagonist SR141716A in conjunction with a VR1 agonist capsaicin in both SHR and Wistar-Kyoto rats (WKY). Mean arterial pressure was increased in SHR compared with WKY (P<0.05). Intravenous administration of capsaicin caused a greater depressor response in SHR compared with WKY (P<0.05), which was blocked by
Revised on November 12, 2002
Anandamide-Induced Depressor Effect in Spontaneously Hypertensive Rats. Role of the Vanilloid Receptor
Jianping Li;
60% by CAPZ (P<0.05) in SHR only. Methanandamide caused a similar greater depressor response (P<0.05), which was blocked by 50% and 60% by CAPZ and SR141716A, respectively, in SHR (P<0.05) but not in WKY. Radioimmunoassay showed that methanandamide increased plasma calcitonin gene-related peptide (CGRP) levels from baseline in both SHR and WKY (P<0.05), with no difference between 2 strains. Western blot showed that protein expression for the calcitonin receptor-like receptor—but not receptor activity modifying protein 1, VR1, and cannabinoid type 1 receptors—was increased in mesenteric resistance arteries in SHR compared with WKY (P<0.05). These data indicate that in addition to activation of cannabinoid type 1, anandamide may serve as an endogenous compound to stimulate VR1, leading to a decrease in blood pressure via CGRP release from sensory nerve terminals. Increased mesenteric CGRP receptor expression in SHR may account for increased sensitivity of blood pressure to anandamide and may serve as a compensatory response to buffer the increase in blood pressure in SHR.
Key words: anandamide • receptors, vanilloid • receptors, cannabinoid • calcitonin gene-related peptide • rats, spontaneously hypertensive
This article has been cited by other articles:
 |
|
 |
|
  F. Gao, D. Sui, R. M. Garavito, R. M. Worden, and D. H. Wang Salt Intake Augments Hypotensive Effects of Transient Receptor Potential Vanilloid 4: Functional Significance and Implication Hypertension, February 1, 2009; 53(2): 228 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pacher, P. Mukhopadhyay, R. Mohanraj, G. Godlewski, S. Batkai, and G. Kunos Modulation of the Endocannabinoid System in Cardiovascular Disease: Therapeutic Potential and Limitations Hypertension, October 1, 2008; 52(4): 601 - 607. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li and D. H. Wang Role of TRPV1 channels in renal haemodynamics and function in Dahl salt-sensitive hypertensive rats Exp Physiol, August 1, 2008; 93(8): 945 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F Birt, M. P Widrlechner, C. A LaLone, L. Wu, J. Bae, A. K. Solco, G. A Kraus, P. A Murphy, E. S Wurtele, Q. Leng, et al. Echinacea in infection Am. J. Clinical Nutrition, February 1, 2008; 87(2): 488S - 492S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. O'Sullivan, M. D. Randall, and S. M. Gardiner The in Vitro and in Vivo Cardiovascular Effects of {Delta}9-Tetrahydrocannabinol in Rats Made Hypertensive by Chronic Inhibition of Nitric-Oxide Synthase J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 663 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, N. E. Kaminski, and D. H. Wang Endocannabinoid Regulates Blood Pressure via Activation of the Transient Receptor Potential Vanilloid Type 1 in Wistar Rats Fed a High-Salt Diet J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 763 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang and D. H. Wang A Novel Mechanism Contributing to Development of Dahl Salt-Sensitive Hypertension: Role of the Transient Receptor Potential Vanilloid Type 1 Hypertension, March 1, 2006; 47(3): 609 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, N. E. Kaminski, and D. H. Wang VR1-Mediated Depressor Effects During High-Salt Intake: Role of Anandamide Hypertension, October 1, 2005; 46(4): 986 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, S. Batkai, D. Osei-Hyiaman, L. Offertaler, J. Liu, J. Harvey-White, A. Brassai, Z. Jarai, B. F. Cravatt, and G. Kunos Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H533 - H541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Batkai, P. Pacher, D. Osei-Hyiaman, S. Radaeva, J. Liu, J. Harvey-White, L. Offertaler, K. Mackie, M. A. Rudd, R. D. Bukoski, et al. Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension Circulation, October 5, 2004; 110(14): 1996 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, S. Batkai, and G. Kunos Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice J. Physiol., July 15, 2004; 558(2): 647 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Okajima, N. Harada, M. Uchiba, and H. Isobe Activation of Capsaicin-Sensitive Sensory Neurons by Carvedilol, a Nonselective {beta}-Blocker, in Spontaneous Hypertensive Rats J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 684 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C.D. Souza, H. C. Salgado, G. Ballejo, and M. C. O. Salgado SR141716A-Sensitive Enhancement of ET-1 Hypotensive Effect by Chronic NOS Inhibition Hypertension, October 1, 2003; 42(4): 802 - 805. [Abstract] [Full Text] [PDF]
|
|